Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 21, 2012; 18(35): 4912-4916
Published online Sep 21, 2012. doi: 10.3748/wjg.v18.i35.4912
Table 2 Clinical and laboratory data at baseline and end of treatment period (mean ± SD) n (%)
VariableBaselineEnd of treatmentP value
Clinical manifestations
Cyanosis9 (90)5 (50)0.12
Dyspnea3 (30)2 (20)1.0
Clubbing7 (70)7 (70)1.0
Palmar erythema5 (50)5 (50)1.0
Hepatomegaly6 (60)6 (60)1.0
Splenomegaly7 (70)7 (70)1.0
Laboratory findings
White blood cell count, × 103/mm6.4 ± 4.414.36 ± 2.040.17
Hemoglobin, g/dL11.25 ± 2.3011.45 ± 2.710.49
Platelet count, × 103/mm³131.6 ± 566.74156.2 ± 498.360.32
Serum creatinine, mg/dL0.56 ± 0.160.6 ± 0.141.0
Serum urea, g/dL12.60 ± 5.9814.70 ± 7.200.34
Serum albumin, g/dL3.88 ± 0.523.56 ± 0.150.59
Serum total protein, g/dL7.20 ± 0.407.26 ± 0.811.0
PT, s15.72 ± 3.0718.51 ± 8..270.40
PTT, s45.50 ± 14.5449.42 ± 11.410.24
INR1.46 ± 0.361.90 ± 1.140.67
Total bilirubin, mg/dL5.73 ± 7.395.07 ± 6.040.17
Direct bilirubin, mg/dL1.70 ± 2.501.68 ± 2.710.83
ALT, U/L83.60 ± 64.2840.60 ± 31.560.27
AST, U/L92.55 ± 64.4866.80 ± 28140.50
ALP, U/L564.66 ± 198.74536.50 ± 17.670.18